(Q42634446)
Statements
1 reference
Dose escalating safety study of a new oral direct thrombin inhibitor, dabigatran etexilate, in patients undergoing total hip replacement: BISTRO I. (English)
1 reference
B I Eriksson
1 reference
O E Dahl
1 reference
L Ahnfelt
1 reference
P Kälebo
1 reference
J Stangier
1 reference
K Hermansson
1 reference
V Kohlbrenner
1 reference
1 September 2004
1 reference
1 reference
2
1 reference
9
1 reference
1573-1580
1 reference
Identifiers
1 reference
1 reference